ZAMRA approves the six-monthly injectable ARV – Lenacapavir for HIV prevention

0
582

The Ministry of Health is pleased to announce that our esteemed regulatory authority, ZAMRA, has approved the six-monthly injectable #ARV – Lenacapavir for HIV prevention.

This marks a major milestone in the fight against HIV, representing a significant step towards reducing new infections and achieving sustainable epidemic control.

We invite members of the media to attend a press briefing at 12:00 hours today, Friday, 7th November 2025, at the Ministry of Health Headquarters.

Members of the public are encouraged to tune in and follow the briefing live on our official platforms as we share more details about this groundbreaking development.

Credit : Ministry of Health